Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Assessment of Current Malaria Status in Light of the Ongoing Control Interventions, Socio-Demographic and Environmental Variables in Jiga Area, Northwest Ethiopia.

Ayalew S, Mamo H, Animut A, Erko B.

PLoS One. 2016 Jan 11;11(1):e0146214. doi: 10.1371/journal.pone.0146214. eCollection 2016.

2.

Simian T-lymphotropic Virus-associated lymphoma in 2 naturally infected baboons: T-cell clonal expansion and immune response during tumor development.

d'Offay JM, Eberle R, Wolf RF, Kosanke SD, Doocy KR, Ayalew S, Mansfeild KG, White GL.

Comp Med. 2013 Jun;63(3):288-94.

3.

Proteomic analysis and immunogenicity of Mannheimia haemolytica vesicles.

Ayalew S, Confer AW, Shrestha B, Wilson AE, Montelongo M.

Clin Vaccine Immunol. 2013 Feb;20(2):191-6. doi: 10.1128/CVI.00622-12. Epub 2012 Dec 12.

4.

The OmpA family of proteins: roles in bacterial pathogenesis and immunity.

Confer AW, Ayalew S.

Vet Microbiol. 2013 May 3;163(3-4):207-22. doi: 10.1016/j.vetmic.2012.08.019. Epub 2012 Aug 31. Review.

PMID:
22986056
5.

A rapid microtiter plate serum bactericidal assay method for determining serum complement-mediated killing of Mannheimia haemolytica.

Ayalew S, Confer AW, Shrestha B, Payton ME.

J Microbiol Methods. 2012 May;89(2):99-101. doi: 10.1016/j.mimet.2012.02.005. Epub 2012 Feb 16.

PMID:
22366301
6.

Immunogenicity of Mannheimia haemolytica recombinant outer membrane proteins serotype 1-specific antigen, OmpA, OmpP2, and OmpD15.

Ayalew S, Shrestha B, Montelongo M, Wilson AE, Confer AW.

Clin Vaccine Immunol. 2011 Dec;18(12):2067-74. doi: 10.1128/CVI.05332-11. Epub 2011 Oct 5.

7.

Identification and immunogenicity of Mannheimia haemolytica S1 outer membrane lipoprotein PlpF.

Ayalew S, Shrestha B, Montelongo M, Wilson AE, Confer AW.

Vaccine. 2011 Nov 3;29(47):8712-8. doi: 10.1016/j.vaccine.2011.08.074. Epub 2011 Aug 27.

PMID:
21875637
8.

Serum antibody responses in horses and mice following immunization with Actinobacillus equuli outer membrane proteins and recombinant Aqx toxin.

Skaggs JS, Reed Holyoak G, Montelongo M, Ayalew S, Confer AW.

Vet J. 2011 Nov;190(2):e91-4. doi: 10.1016/j.tvjl.2011.04.006. Epub 2011 May 18.

PMID:
21596597
9.

Immunoproteomic analyses of outer membrane proteins of Mannheimia haemolytica and identification of potential vaccine candidates.

Ayalew S, Confer AW, Hartson SD, Shrestha B.

Proteomics. 2010 Jun;10(11):2151-64. doi: 10.1002/pmic.200900557.

PMID:
20336679
10.

Vacuolar ATPase regulates surfactant secretion in rat alveolar type II cells by modulating lamellar body calcium.

Chintagari NR, Mishra A, Su L, Wang Y, Ayalew S, Hartson SD, Liu L.

PLoS One. 2010 Feb 16;5(2):e9228. doi: 10.1371/journal.pone.0009228.

11.

Intranasal vaccination of calves with Mannheimia haemolytica chimeric protein containing the major surface epitope of outer membrane lipoprotein PlpE, the neutralizing epitope of leukotoxin, and cholera toxin subunit B.

Ayalew S, Step DL, Montelongo M, Confer AW.

Vet Immunol Immunopathol. 2009 Dec 15;132(2-4):295-302. doi: 10.1016/j.vetimm.2009.06.005. Epub 2009 Jun 17.

PMID:
19581005
12.

Intranasal vaccination of young Holstein calves with Mannheimia haemolytica chimeric protein PlpE-LKT (SAC89) and cholera toxin.

Confer AW, Ayalew S, Step DL, Trojan B, Montelongo M.

Vet Immunol Immunopathol. 2009 Dec 15;132(2-4):232-6. doi: 10.1016/j.vetimm.2009.04.018. Epub 2009 May 4. No abstract available.

PMID:
19477022
13.

Immunity of cattle following vaccination with a Mannheimia haemolytica chimeric PlpE-LKT (SAC89) protein.

Confer AW, Ayalew S, Montelongo M, Step DL, Wray JH, Hansen RD, Panciera RJ.

Vaccine. 2009 Mar 10;27(11):1771-6. doi: 10.1016/j.vaccine.2008.09.028. Epub 2008 Oct 1.

PMID:
18834912
14.

Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin.

Ayalew S, Confer AW, Payton ME, Garrels KD, Shrestha B, Ingram KR, Montelongo MA, Taylor JD.

Vaccine. 2008 Sep 8;26(38):4955-61. doi: 10.1016/j.vaccine.2008.07.023. Epub 2008 Jul 31.

PMID:
18675308
15.

Proteomic analysis of lamellar bodies isolated from rat lungs.

Wang P, Chintagari NR, Narayanaperumal J, Ayalew S, Hartson S, Liu L.

BMC Cell Biol. 2008 Jun 24;9:34. doi: 10.1186/1471-2121-9-34.

16.

Serum antibodies in mares and foals to Actinobacillus equuli whole cells, outer membrane proteins, and Aqx toxin.

Holyoak GR, Smith CM, Boyette R, Montelongo M, Wray JH, Ayalew S, Duggan VE, Confer AW.

Vet Immunol Immunopathol. 2007 Aug 15;118(3-4):310-6. Epub 2007 Jun 3.

PMID:
17604847
17.

Recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE enhances commercial M. haemolytica vaccine-induced resistance against serotype 6 challenge.

Confer AW, Ayalew S, Panciera RJ, Montelongo M, Wray JH.

Vaccine. 2006 Mar 20;24(13):2248-55. Epub 2005 Dec 9.

PMID:
16430995
18.

Sequence diversity of the immunogenic outer membrane lipoprotein PlpE from Mannheimia haemolytica serotypes 1, 2, and 6.

Ayalew S, Blackwood ER, Confer AW.

Vet Microbiol. 2006 May 31;114(3-4):260-8. Epub 2006 Jan 4.

PMID:
16386856
20.

Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine.

Confer AW, Ayalew S, Panciera RJ, Montelongo M, Whitworth LC, Hammer JD.

Vaccine. 2003 Jun 20;21(21-22):2821-9.

PMID:
12798623
Items per page

Supplemental Content

Loading ...
Write to the Help Desk